Embryonic stem cell therapy for diabetes mellitus

Kevin Docherty, Andreia S. Bernardo, Ludovic Vallier

Research output: Contribution to journalLiterature review

32 Citations (Scopus)

Abstract

There is a compelling need to develop novel therapies for diabetes mellitus. Recent successes in the transplantation of islets of Langerhans are seen as a major breakthrough. However, there is huge disparity between potential recipients and the availability of donor tissue. Human embryonic stem cells induced to form pancreatic beta cells could provide a replenishable supply of tissue. Early studies on the spontaneous differentiation of mouse embryonic stem cells have laid the foundation for a more directed approach based on recapitulating the events that occur during the development of the pancreas in the mouse. A high yield of definitive endoderm has been achieved, and although beta-like cells can be generated in a step-wise manner, the efficiency is still low and the final product is not fully differentiated. Future challenges include generating fully functional islet cells under Xeno-free and chemically defined conditions and circumventing the need for immunosuppression.

Original languageEnglish
Pages (from-to)827-838
Number of pages12
JournalSeminars in Cell & Developmental Biology
Volume18
Issue number6
Early online date11 Sep 2007
DOIs
Publication statusPublished - Dec 2007

Keywords

  • differentiation
  • Pdx1
  • insulin gene
  • regenerative medicine
  • cell therapy
  • pancreas development
  • insulin-producing cells
  • pancreatic beta-cells
  • in-vitro
  • islet transplantation
  • definitive endoderm
  • expressing cells
  • nuclear transfer
  • gene-expression
  • ex-vivo
  • directed differentiation

Cite this

Embryonic stem cell therapy for diabetes mellitus. / Docherty, Kevin; Bernardo, Andreia S.; Vallier, Ludovic.

In: Seminars in Cell & Developmental Biology, Vol. 18, No. 6, 12.2007, p. 827-838.

Research output: Contribution to journalLiterature review

Docherty, Kevin ; Bernardo, Andreia S. ; Vallier, Ludovic. / Embryonic stem cell therapy for diabetes mellitus. In: Seminars in Cell & Developmental Biology. 2007 ; Vol. 18, No. 6. pp. 827-838.
@article{3716e9803c534e158e5f3ad23fcc0206,
title = "Embryonic stem cell therapy for diabetes mellitus",
abstract = "There is a compelling need to develop novel therapies for diabetes mellitus. Recent successes in the transplantation of islets of Langerhans are seen as a major breakthrough. However, there is huge disparity between potential recipients and the availability of donor tissue. Human embryonic stem cells induced to form pancreatic beta cells could provide a replenishable supply of tissue. Early studies on the spontaneous differentiation of mouse embryonic stem cells have laid the foundation for a more directed approach based on recapitulating the events that occur during the development of the pancreas in the mouse. A high yield of definitive endoderm has been achieved, and although beta-like cells can be generated in a step-wise manner, the efficiency is still low and the final product is not fully differentiated. Future challenges include generating fully functional islet cells under Xeno-free and chemically defined conditions and circumventing the need for immunosuppression.",
keywords = "differentiation, Pdx1, insulin gene, regenerative medicine, cell therapy, pancreas development, insulin-producing cells, pancreatic beta-cells, in-vitro, islet transplantation, definitive endoderm, expressing cells, nuclear transfer, gene-expression, ex-vivo, directed differentiation",
author = "Kevin Docherty and Bernardo, {Andreia S.} and Ludovic Vallier",
year = "2007",
month = "12",
doi = "10.1016/j.semcdb.2007.09.009",
language = "English",
volume = "18",
pages = "827--838",
journal = "Seminars in Cell & Developmental Biology",
issn = "1084-9521",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Embryonic stem cell therapy for diabetes mellitus

AU - Docherty, Kevin

AU - Bernardo, Andreia S.

AU - Vallier, Ludovic

PY - 2007/12

Y1 - 2007/12

N2 - There is a compelling need to develop novel therapies for diabetes mellitus. Recent successes in the transplantation of islets of Langerhans are seen as a major breakthrough. However, there is huge disparity between potential recipients and the availability of donor tissue. Human embryonic stem cells induced to form pancreatic beta cells could provide a replenishable supply of tissue. Early studies on the spontaneous differentiation of mouse embryonic stem cells have laid the foundation for a more directed approach based on recapitulating the events that occur during the development of the pancreas in the mouse. A high yield of definitive endoderm has been achieved, and although beta-like cells can be generated in a step-wise manner, the efficiency is still low and the final product is not fully differentiated. Future challenges include generating fully functional islet cells under Xeno-free and chemically defined conditions and circumventing the need for immunosuppression.

AB - There is a compelling need to develop novel therapies for diabetes mellitus. Recent successes in the transplantation of islets of Langerhans are seen as a major breakthrough. However, there is huge disparity between potential recipients and the availability of donor tissue. Human embryonic stem cells induced to form pancreatic beta cells could provide a replenishable supply of tissue. Early studies on the spontaneous differentiation of mouse embryonic stem cells have laid the foundation for a more directed approach based on recapitulating the events that occur during the development of the pancreas in the mouse. A high yield of definitive endoderm has been achieved, and although beta-like cells can be generated in a step-wise manner, the efficiency is still low and the final product is not fully differentiated. Future challenges include generating fully functional islet cells under Xeno-free and chemically defined conditions and circumventing the need for immunosuppression.

KW - differentiation

KW - Pdx1

KW - insulin gene

KW - regenerative medicine

KW - cell therapy

KW - pancreas development

KW - insulin-producing cells

KW - pancreatic beta-cells

KW - in-vitro

KW - islet transplantation

KW - definitive endoderm

KW - expressing cells

KW - nuclear transfer

KW - gene-expression

KW - ex-vivo

KW - directed differentiation

U2 - 10.1016/j.semcdb.2007.09.009

DO - 10.1016/j.semcdb.2007.09.009

M3 - Literature review

VL - 18

SP - 827

EP - 838

JO - Seminars in Cell & Developmental Biology

JF - Seminars in Cell & Developmental Biology

SN - 1084-9521

IS - 6

ER -